71 - 80 out of 135Page size: 10
Sort by: Title

  1. Novel Peptide–Drug Conjugates with Dual Anticancer Activity

    O’Flaherty, S., Luzina, O. A., Dyrkheeva, N. S., Krier, Y., Leprince, J., Zakharenko, A. L., Pokrovsky, M. A., Pokrovsky, A. G., Lavrik, O. I., Salakhutdinov, N. F., Varbanov, M., Devocelle, M. & Volcho, K. P., 19 Nov 2024, In: International Journal of Molecular Sciences. 25, 22, 12411.

    Research output: Contribution to journal › Article › peer-review

  2. Novel semisynthetic derivatives of bile acids as effective tyrosyl-DNA phosphodiesterase 1 inhibitors

    Salomatina, O. V., Popadyuk, I. I., Zakharenko, A. L., Zakharova, O. D., Fadeev, D. S., Komarova, N. I., Reynisson, J., Arabshahi, H. J., Chand, R., Volcho, K. P., Salakhutdinov, N. F. & Lavrik, O. I., 17 Mar 2018, In: Molecules. 23, 3, 19 p., 679.

    Research output: Contribution to journal › Article › peer-review

  3. Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties

    Ivankin, D. I., Kornienko, T. E., Mikhailova, M. A., Dyrkheeva, N. S., Zakharenko, A. L., Achara, C., Reynisson, J., Golyshev, V. M., Luzina, O. A., Volcho, K. P., Salakhutdinov, N. F. & Lavrik, O. I., 14 Feb 2023, In: International Journal of Molecular Sciences. 24, 4, 3834.

    Research output: Contribution to journal › Article › peer-review

  4. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models

    Zakharenko, A. L., Luzina, O. A., Sokolov, D. N., Kaledin, V. I., Nikolin, V. P., Popova, N. A., Patel, J., Zakharova, O. D., Chepanova, A. A., Zafar, A., Reynisson, J., Leung, E., Leung, I. K. H., Volcho, K. P., Salakhutdinov, N. F. & Lavrik, O. I., 1 Jan 2019, In: European Journal of Medicinal Chemistry. 161, p. 581-593 13 p.

    Research output: Contribution to journal › Article › peer-review

  5. Nucleotide excision repair: From molecular defects to neurological abnormalities

    Krasikova, Y., Rechkunova, N. & Lavrik, O., 2 Jun 2021, In: International Journal of Molecular Sciences. 22, 12, 6220.

    Research output: Contribution to journal › Review article › peer-review

  6. Optimization of nucleosome assembling from histones and model DNAs and estimation of the reconstitution efficiency

    Kutuzov, M. M., Kurgina, T. A., Belousova, E. A., Khodyreva, S. N. & Lavrik, O. I., 1 Feb 2019, In: Biopolymers and Cell. 35, 2, p. 91-98 8 p.

    Research output: Contribution to journal › Article › peer-review

  7. PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA

    Singatulina, A. S., Hamon, L., Sukhanova, M. V., Desforges, B., Joshi, V., Bouhss, A., Lavrik, O. I. & Pastré, D., 7 May 2019, In: Cell Reports. 27, 6, p. 1809-1821.e5 18 p.

    Research output: Contribution to journal › Article › peer-review

  8. PARP1, PARP2 and PARP3 interaction with nucleosomes containing DNA-lesions

    Kurgina, T. A., Kutuzov, M. M., Belousova, E. A., Ukraitsev, A. A., Anarbaev, R. O. & Lavrik, O. I., Jul 2021, In: FEBS Open Bio. 11, p. 244-245 2 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  9. PARP1 Regulates the Biogenesis and Activity of Telomerase Complex Through Modification of H/ACA-Proteins

    Savelyev, N. V., Shepelev, N. M., Lavrik, O. I., Rubtsova, M. P. & Dontsova, O. A., 19 May 2021, In: Frontiers in Cell and Developmental Biology. 9, 621134.

    Research output: Contribution to journal › Article › peer-review

  10. PARPs’ impact on base excision DNA repair

    Lavrik, O. I., Sept 2020, In: DNA Repair. 93, p. 102911 6 p., 102911.

    Research output: Contribution to journal › Review article › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...14 Next

ID: 3458125